Premium
Genetic polymorphism of N ‐acetyltransferase 2 in the susceptibility to laryngeal squamous cell carcinoma
Author(s) -
Ünal Murat,
Tamer Lülüfer,
Akbaş Yücel,
Pata Yavuz Selim,
Vayisoǧlu Yusuf,
Deǧirmenci Ulaş,
Çamdeviren Handan
Publication year - 2005
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.20284
Subject(s) - genotype , heterozygote advantage , allele , gastroenterology , medicine , biology , allele frequency , odds ratio , population , genetics , gene , environmental health
Abstract Background. The purpose of this study was to investigate whether polymorphism of N ‐acetyltransferase 2 ( NAT2 ) genotypes are associated with the risk of laryngeal squamous cell carcinoma (SCC). Methods. The study group consisted of 45 white patients with laryngeal SCC (42 men, with a mean age of 54 years [range, 37–70 years] and three women, with a mean age of 47 years [range, 32–55 years]) and 104 control subjects (68 men and 36 women; mean age, 50 years; range, 28–73 years). All of the patients were primarily treated with surgical intervention. Blood samples (5 mL) were obtained before surgery or from the patients under follow‐up to 5 years after surgery (mean follow‐up, 27 months; range, 6–48 months). DNA was extracted from the lymphocytes by high pure template preparation kit. NAT2 *5A, NAT2 *6A, NAT2 *7A/B, and NAT2 *14A were detected by use of LightCycler‐ NAT2 mutation detection kit by real‐time polymerase chain reaction with Light Cycler instruments. The association between NAT2 polymorphisms and laryngeal SCC was prospectively modeled through multivariate logistic regression analysis. Results. We found that the risk of laryngeal SCC was 7.3‐fold higher in individuals with NAT2 *5 mutant allele, 3.8‐fold higher in subjects with NAT2 *6 heterozygote allele, and 38.3‐fold higher in NAT2 *6 mutant allele. We also found that individuals with NAT2 *7 heterozygote allele had a 0.2‐fold less risk for the development of laryngeal SCC ( p = .018). Conclusion. In this population, patients with NAT2 *5 mutant and *6 heterozygous and mutant genotypes had a significantly higher risk for development of laryngeal SCC. © 2005 Wiley Periodicals, Inc. Head Neck 27: XXX–XXX, 2005